In gestation: New OTC reproductive health products

News
Article

Instead Inc. launches several new OTC products, including a disposable diaphragm and non-greasy seaweed-based vaginal lubricant gel.

Recent Videos
Related Content
FDA Approves Ceftobiprole Medocaril Sodium for 3 Indications

FDA Approves Ceftobiprole Medocaril Sodium for 3 Indications

Jenny Zhao, PharmD;Kevin W. Chamberlin, PharmD, FASCP
October 14th 2024
Article

The FDA approved ceftobiprole medocaril sodium for injection (Zevtera) in April 2024.

Over the Counter podcast

Episode 8: Stay in Sync with Innovations in Medication Decision Support

Drug Topics staff
August 6th 2020
Podcast

Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.

FDA Approves First Weekly Subcutaneous Therapy for Hemophilia B

FDA Approves First Weekly Subcutaneous Therapy for Hemophilia B

Lauren Massaro
October 11th 2024
Article

Marstacimab-hncq is the first non-factor and once-weekly treatment available for patients with hemophilia B and promises to reduce the burden of care.

FDA Approves Imuldosa, Biosimilar to Stelara

FDA Approves Imuldosa, Biosimilar to Stelara

Lauren Massaro
October 11th 2024
Article

The approval is supported by results from phase 3 multi-regional clinical trials conducted in patients with plaque psoriasis.

FDA Accepts Bayer’s NDA for Elinzanetant to Treat Menopause Symptoms

FDA Accepts Bayer’s NDA for Elinzanetant to Treat Menopause Symptoms

Lauren Massaro
October 10th 2024
Article

The therapy’s Prescription Drug User Fee Act date has been set for July 26, 2025.

FDA Roundup: Biosimilar Approval, Hereditary Angioedema Treatment Receives Orphan Drug Designation

FDA Roundup: Biosimilar Approval, Hereditary Angioedema Treatment Receives Orphan Drug Designation

Killian Meara
October 4th 2024
Article

Check out important updates from the FDA for the week of September 30.

© 2024 MJH Life Sciences

All rights reserved.